The FDA Wants To Hear Patients’ Voices

January 27, 2016

The FDA Wants To Hear Patients’ Voices by Joanne McNelis, Ph.D., Scientist at Cato Research In September the FDA announced...


‘Inhibit the inhibitor’ – it’s all about PD-(L)1 inhibitors in cancer treatment

March 30, 2015

PD-1 and PD-L1 inhibitors are the hot topic in oncology drug development at the moment, as underscored by numerous speakers...


Top Five Mistakes in Clinical Protocol Design

October 9, 2014

By Lisa R. Sanders, Ph.D., R.A.C., Sr. Clinical Scientist II Almost a Holy Grail for the pharma/biotech world, the perfect...